{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:16:11Z","timestamp":1789042571566,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08886-5","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T09:15:00Z","timestamp":1788167700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multi-omics characterization of a GPRC5A+ epithelial subpopulation associated with malignant features in colorectal cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Weichun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengchen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guizhen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"issue":"25","key":"8886_CR1","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1200\/JCO.23.01889","volume":"42","author":"H Hu","year":"2024","unstructured":"Hu H, Zhang J, Li Y, Wang X, Wang Z, Wang H, et al. Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase III OPTICAL trial. J Clin Oncol: Off J Am Soc Clin Oncol. 2024;42(25):2978\u201388. https:\/\/doi.org\/10.1200\/JCO.23.01889.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"1","key":"8886_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA: Cancer J Clinicians. 2025;75(1):10\u201345. https:\/\/doi.org\/10.3322\/caac.21871.","journal-title":"CA: Cancer J Clinicians"},{"issue":"24","key":"8886_CR3","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1200\/JCO.23.01680","volume":"42","author":"JA Nowak","year":"2024","unstructured":"Nowak JA, Twombly T, Ma C, Shi Q, Haruki K, Fujiyoshi K, et al. Improved survival with adjuvant cyclooxygenase 2 inhibition in PIK3CA-activated stage III colon cancer: CALGB\/SWOG 80702 (Alliance). J Clin Oncol: Off J Am Soc Clin Oncol. 2024;42(24):2853\u201359. https:\/\/doi.org\/10.1200\/JCO.23.01680.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"issue":"1","key":"8886_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12943-025-02426-3","volume":"24","author":"J Le","year":"2025","unstructured":"Le J, Dian Y, Zhao D, Guo Z, Luo Z, Chen X, et al. Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment. Mol Cancer. 2025;24(1):221. https:\/\/doi.org\/10.1186\/s12943-025-02426-3.","journal-title":"Mol Cancer"},{"issue":"8","key":"8886_CR5","doi-asserted-by":"publisher","first-page":"3680","DOI":"10.1016\/j.ymthe.2025.05.004","volume":"33","author":"Y Gao","year":"2025","unstructured":"Gao Y, Zhang X, Xia S, Chen Q, Tong Q, Yu S, et al. Spatial multi-omics reveals the potential involvement of SPP1(+) fibroblasts in determining metabolic heterogeneity and promoting metastatic growth of colorectal cancer liver metastasis. Mol Ther. 2025;33(8):3680\u2013700. https:\/\/doi.org\/10.1016\/j.ymthe.2025.05.004.","journal-title":"Mol Ther"},{"issue":"6","key":"8886_CR6","first-page":"618","volume":"22","author":"K Zhou","year":"2025","unstructured":"Zhou K, Yang C, Li Y. Multi-omics in colorectal cancer liver metastasis: applications and research advances. Cancer Biol Med. 2025;22(6):618\u201338.","journal-title":"Cancer Biol Med"},{"key":"8886_CR7","doi-asserted-by":"publisher","first-page":"101063","DOI":"10.1016\/j.drup.2024.101063","volume":"73","author":"X Ou","year":"2024","unstructured":"Ou X, Tan Y, Xie J, Yuan J, Deng X, Shao R, et al. Methylation of GPRC5A promotes liver metastasis and docetaxel resistance through activating mTOR signaling pathway in triple negative breast cancer. Drug Resist Updat: Rev Comment Antimicrob Anticancer Chemother. 2024. 73:101063.","journal-title":"Drug Resist Updat: Rev Comment Antimicrob Anticancer Chemother"},{"issue":"1","key":"8886_CR8","doi-asserted-by":"publisher","first-page":"9950","DOI":"10.1038\/s41467-024-54251-9","volume":"15","author":"H Zhou","year":"2024","unstructured":"Zhou H, Tan L, Zhang B, Kwong DLW, Wong CN, Zhang Y, et al. GPRC5A promotes lung colonization of esophageal squamous cell carcinoma. Nat Commun. 2024;15(1):9950. https:\/\/doi.org\/10.1038\/s41467-024-54251-9.","journal-title":"Nat Commun"},{"issue":"1","key":"8886_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41420-022-00814-y","volume":"8","author":"D Liu","year":"2022","unstructured":"Liu D, Jin Y, Wu J, Zhu H, Ye D. MiR-135b-5p is an oncogene in pancreatic cancer to regulate GPRC5A expression by targeting transcription factor KLF4. Cell Death Discov. 2022;8(1):23. https:\/\/doi.org\/10.1038\/s41420-022-00814-y.","journal-title":"Cell Death Discov"},{"issue":"8","key":"8886_CR10","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1002\/ijc.30851","volume":"141","author":"J Fujimoto","year":"2017","unstructured":"Fujimoto J, Nunomura-Nakamura S, Liu Y, Lang W, McDowell T, Jakubek Y, et al. Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a. Int J Cancer. 2017;141(8):1589\u201399.","journal-title":"Int J Cancer"},{"key":"8886_CR11","doi-asserted-by":"publisher","first-page":"217067","DOI":"10.1016\/j.canlet.2024.217067","volume":"598","author":"J Yang","year":"2024","unstructured":"Yang J, Li X, Chen S, Li G, Pu P, Yang Y, et al. GPRC5A promotes gallbladder cancer metastasis by upregulating TNS4 via the JAK2-STAT3 pathway. Cancer Lett. 2024;598:217067. https:\/\/doi.org\/10.1016\/j.canlet.2024.217067.","journal-title":"Cancer Lett"},{"issue":"Pt 1","key":"8886_CR12","doi-asserted-by":"publisher","first-page":"147059","DOI":"10.1016\/j.ijbiomac.2025.147059","volume":"323","author":"Y Xu","year":"2025","unstructured":"Xu Y, Zhang C, Wu J, Qiu M, Zhu M, Wang C, et al. Integrating single-cell RNA sequencing and spatial transcriptomics to reveal the glycolysis-related gene GPRC5A as a potential biomarker for gastric cancer by machine learning. Int J Biol Macromolecules. 2025;323(Pt 1):147059. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.147059.","journal-title":"Int J Biol Macromolecules"},{"issue":"1","key":"8886_CR13","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3164\/jcbn.22-125","volume":"73","author":"L Zhang","year":"2023","unstructured":"Zhang L, Yang W, Yang J, Sun F. GPRC5A regulates proliferation and oxidative stress by inhibiting the STAT3\/Socs3\/c-MYC pathway in hepatocellular carcinoma. J Clin Biochem Nutr. 2023;73(1):43\u201351. https:\/\/doi.org\/10.3164\/jcbn.22-125.","journal-title":"J Clin Biochem Nutr"},{"issue":"1","key":"8886_CR14","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s12935-022-02466-5","volume":"22","author":"Y Liu","year":"2022","unstructured":"Liu Y, Bai Z, Chai D, Gao Y, Li T, Ma Y, et al. DNA methyltransferase 1 inhibits microRNA-497 and elevates GPRC5A expression to promote chemotherapy resistance and metastasis in breast cancer. Cancer Cell Int. 2022;22(1):112. https:\/\/doi.org\/10.1186\/s12935-022-02466-5.","journal-title":"Cancer Cell Int"},{"key":"8886_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12935-017-0406-x","volume":"17","author":"S Liu","year":"2017","unstructured":"Liu S, Ye D, Wang T, Guo W, Song H, Liao Y, et al. Repression of GPRC5A is associated with activated STAT3, which contributes to tumor progression of head and neck squamous cell carcinoma. Cancer Cell Int. 2017;17:34. https:\/\/doi.org\/10.1186\/s12935-017-0406-x.","journal-title":"Cancer Cell Int"},{"key":"8886_CR16","doi-asserted-by":"publisher","unstructured":"Iglesias Gonz\u00e1lez PA, Mori C, Valdivieso \u00c1G, Santa Coloma TA. Vitamin D and retinoic acid require protein kinase C activity and reactive oxygen species as opposing signals regulating PEIG-1\/GPRC5A expression in caco-2 and T84 colon carcinoma cells. Biomolecules. 2025;15(5). https:\/\/doi.org\/10.3390\/biom15050711.","DOI":"10.3390\/biom15050711"},{"issue":"1","key":"8886_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s13046-023-02915-7","volume":"42","author":"Z Chen","year":"2023","unstructured":"Chen Z, Li Y, He K, Yang J, Deng Q, Chen Y, et al. CircGPRC5A enhances colorectal cancer progress by stabilizing PPP1CA and inducing YAP dephosphorylation. J Exp Clin Cancer Res. 2023;42(1):334. https:\/\/doi.org\/10.1186\/s13046-023-02915-7.","journal-title":"J Exp Clin Cancer Res"},{"key":"8886_CR18","doi-asserted-by":"publisher","unstructured":"Greenhough A, Bagley C, Heesom KJ, Gurevich DB, Gay D, Bond M, et al. Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis. EMBO Mol Med. 2018;10(11). https:\/\/doi.org\/10.15252\/emmm.201708699.","DOI":"10.15252\/emmm.201708699"},{"issue":"12","key":"8886_CR19","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1002\/ijc.30698","volume":"140","author":"L Zhang","year":"2017","unstructured":"Zhang L, Li L, Gao G, Wei G, Zheng Y, Wang C, et al. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress. Int J Cancer. 2017;140(12):2734\u201347. https:\/\/doi.org\/10.1002\/ijc.30698.","journal-title":"Int J Cancer"},{"key":"8886_CR20","doi-asserted-by":"publisher","unstructured":"Szeglin BC, Wu C, Marco MR, Park HS, Zhang Z, Zhang B, et al. A SMAD4-modulated gene profile predicts disease-free survival in stage II and III colorectal cancer. Cancer Rep (Hoboken, NJ). 2022;5(1):e 1423. https:\/\/doi.org\/10.1002\/cnr2.1423.","DOI":"10.1002\/cnr2.1423"},{"key":"8886_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejca.2017.02.003","volume":"76","author":"M Del Rio","year":"2017","unstructured":"Del Rio M, Mollevi C, Bibeau F, Vie N, Selves J, Emile JF, et al. Molecular subtypes of metastatic colorectal cancer are associated with patient response to irinotecan-based therapies. Eur J Cancer (Oxford, England: 1990). Vol. 76. 2017. p. 68\u201375.","journal-title":"Eur J Cancer"},{"key":"8886_CR22","doi-asserted-by":"publisher","unstructured":"Marisa L, de Reyni\u00e8s A, Duval A, Selves J, Gaub MP, Vescovo L, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013;10(5):e1001453. https:\/\/doi.org\/10.1371\/journal.pmed.1001453.","DOI":"10.1371\/journal.pmed.1001453"},{"issue":"23","key":"8886_CR23","doi-asserted-by":"publisher","first-page":"6947","DOI":"10.1158\/0008-5472.CAN-14-1592","volume":"74","author":"MK Tripathi","year":"2014","unstructured":"Tripathi MK, Deane NG, Zhu J, An H, Mima S, Wang X, et al. Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer. Cancer Res. 2014;74(23):6947\u201357. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1592.","journal-title":"Cancer Res"},{"key":"8886_CR24","doi-asserted-by":"publisher","unstructured":"Sol\u00e9 X, Crous-Bou M, Cordero D, Olivares D, Guin\u00f3 E, Sanz-Pamplona R, et al. Discovery and validation of new potential biomarkers for early detection of colon cancer. PLoS One. 2014;9(9):e106748. https:\/\/doi.org\/10.1371\/journal.pone.0106748.","DOI":"10.1371\/journal.pone.0106748"},{"issue":"18","key":"8886_CR25","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka K, Hofree M, Chen JH, Sarkizova S, Pirl JD, Jorgji V, et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell. 2021;184(18):4734\u201352.e20. https:\/\/doi.org\/10.1016\/j.cell.2021.08.003.","journal-title":"Cell"},{"issue":"6","key":"8886_CR26","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","volume":"52","author":"HO Lee","year":"2020","unstructured":"Lee HO, Hong Y, Etlioglu HE, Cho YB, Pomella V, Van den Bosch B, et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat Genet. 2020;52(6):594\u2013603. https:\/\/doi.org\/10.1038\/s41588-020-0636-z.","journal-title":"Nat Genet"},{"key":"8886_CR27","doi-asserted-by":"publisher","unstructured":"Uhlitz F, Bischoff P, Peidli S, Sieber A, Trinks A, L\u00fcthen M, et al. Mitogen-activated protein kinase activity drives cell trajectories in colorectal cancer. EMBO Mol Med. 2021;13(10):e14123. https:\/\/doi.org\/10.15252\/emmm.202114123.","DOI":"10.15252\/emmm.202114123"},{"issue":"1","key":"8886_CR28","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1158\/2159-8290.CD-21-0316","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Yang S, Ma J, Chen Z, Song G, Rao D, et al. Spatiotemporal immune landscape colorectal cancer liver metastasis single-cell level. Cancer Discov. 2022;12(1):134\u201353. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0316.","journal-title":"Cancer Discov"},{"issue":"1","key":"8886_CR29","doi-asserted-by":"publisher","first-page":"9232","DOI":"10.1038\/s41467-025-64292-3","volume":"16","author":"P Ren","year":"2025","unstructured":"Ren P, Zhang R, Wang Y, Zhang P, Luo C, Wang S, et al. Systematic benchmarking of high-throughput subcellular spatial transcriptomics platforms across human tumors. Nat Commun. 2025;16(1):9232. https:\/\/doi.org\/10.1038\/s41467-025-64292-3.","journal-title":"Nat Commun"},{"issue":"12","key":"8886_CR30","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","volume":"16","author":"I Korsunsky","year":"2019","unstructured":"Korsunsky I, Millard N, Fan J, Slowikowski K, Zhang F, Wei K, et al. Fast, sensitive and accurate integration of single-cell data with Harmony. Nat Methods. 2019;16(12):1289\u201396. https:\/\/doi.org\/10.1038\/s41592-019-0619-0.","journal-title":"Nat Methods"},{"key":"8886_CR31","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: an update to the integrated cancer data analysis platform. Neoplasia (New Y, NY). 2022;25:18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001.","journal-title":"Neoplasia"},{"issue":"2","key":"8886_CR32","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372. https:\/\/doi.org\/10.1038\/s41590-018-0276-y.","journal-title":"Nat Immunol"},{"key":"8886_CR33","doi-asserted-by":"publisher","unstructured":"Hu C, Li T, Xu Y, Zhang X, Li F, Bai J, et al. CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data. Nucleic Acids Res. 2023;51(D1):D870\u2013d6. https:\/\/doi.org\/10.1093\/nar\/gkac947.","DOI":"10.1093\/nar\/gkac947"},{"issue":"1","key":"8886_CR34","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12(1):1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"issue":"5","key":"8886_CR35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y, et al. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol. 2021;39(5):599\u2013608. https:\/\/doi.org\/10.1038\/s41587-020-00795-2.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"8886_CR36","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1038\/s41587-022-01233-1","volume":"40","author":"R Wei","year":"2022","unstructured":"Wei R, He S, Bai S, Sei E, Hu M, Thompson A, et al. Spatial charting of single-cell transcriptomes in tissues. Nat Biotechnol. 2022;40(8):1190\u201399. https:\/\/doi.org\/10.1038\/s41587-022-01233-1.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"8886_CR37","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1101\/gr.276851.122","volume":"32","author":"Q Liu","year":"2022","unstructured":"Liu Q, Hsu CY, Shyr Y. Scalable and model-free detection of spatial patterns and colocalization. Genome Res. 2022;32(9):1736\u201345. https:\/\/doi.org\/10.1101\/gr.276851.122.","journal-title":"Genome Res"},{"issue":"11","key":"8886_CR38","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar S, Gonz\u00e1lez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. SCENIC: single-cell regulatory network inference and clustering. Nat Methods. 2017;14(11):1083\u201386. https:\/\/doi.org\/10.1038\/nmeth.4463.","journal-title":"Nat Methods"},{"issue":"1","key":"8886_CR39","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13072-024-00559-1","volume":"17","author":"Q He","year":"2024","unstructured":"He Q, Hu J, Huang H, Wu T, Li W, Ramakrishnan S, et al. FOSL1 is a key regulator of a super-enhancer driving TCOF1 expression in triple-negative breast cancer. Epigenet Chromatin. 2024;17(1):34. https:\/\/doi.org\/10.1186\/s13072-024-00559-1.","journal-title":"Epigenet Chromatin"},{"key":"8886_CR40","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Briefings Bioinf. 2021;22(6). https:\/\/doi.org\/10.1093\/bib\/bbab260.","DOI":"10.1093\/bib\/bbab260"},{"issue":"1","key":"8886_CR41","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1038\/s41467-023-37179-4","volume":"14","author":"PC Tsai","year":"2023","unstructured":"Tsai PC, Lee TH, Kuo KC, Su FY, Lee TM, Marostica E, et al. Histopathology images predict multi-omics aberrations and prognoses in colorectal cancer patients. Nat Commun. 2023;14(1):2102.","journal-title":"Nat Commun"},{"key":"8886_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","volume":"88","author":"X He","year":"2023","unstructured":"He X, Liu X, Zuo F, Shi H, Jing J. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine. Semin Cancer Biol. 2023;88:187\u2013200. https:\/\/doi.org\/10.1016\/j.semcancer.2022.12.009.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"8886_CR43","doi-asserted-by":"publisher","first-page":"167535","DOI":"10.1016\/j.bbadis.2024.167535","volume":"1871","author":"S Hu","year":"2025","unstructured":"Hu S, Qin J, Ding M, Gao R, Xiao Q, Lou J, et al. Bulk integrated single-cell-spatial transcriptomics reveals the impact of preoperative chemotherapy on cancer-associated fibroblasts and tumor cells in colorectal cancer, and construction of related predictive models using machine learning. Biochim Et Biophys Acta Mol Basis Disease. 2025;1871(1):167535. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167535.","journal-title":"Biochim Et Biophys Acta Mol Basis Disease"},{"issue":"4","key":"8886_CR44","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/mc.23882","volume":"64","author":"J Qin","year":"2025","unstructured":"Qin J, Hu S, Chen Y, Xu M, Xiao Q, Lou J, et al. Hypoxia promotes malignant progression of colorectal cancer by inducing POSTN(+) cancer-associated fibroblast formation. Mol CarcinogMolecular Carcinog. 2025;64(4):716\u201332. https:\/\/doi.org\/10.1002\/mc.23882.","journal-title":"Mol CarcinogMolecular Carcinog"},{"key":"8886_CR45","doi-asserted-by":"publisher","first-page":"0950","DOI":"10.34133\/research.0950","volume":"8","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Zhang K, Wu W, Zhou J, Zhang M, Chen J, et al. POSTN(+) CAF-derived migrasomes drive hepatocellular carcinoma progression and confer resistance to immunotherapy. Research (Washington, DC). 2025;8. 0950.","journal-title":"Research"},{"key":"8886_CR46","doi-asserted-by":"publisher","unstructured":"Dai L, Jin X, Liu Z. Prognostic and clinicopathological significance of GPRC5A in various cancers: a systematic review and meta-analysis. PLoS One. 2021;16(3):e0249040. https:\/\/doi.org\/10.1371\/journal.pone.0249040.","DOI":"10.1371\/journal.pone.0249040"},{"issue":"1","key":"8886_CR47","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41419-025-07711-z","volume":"16","author":"B Dayanc","year":"2025","unstructured":"Dayanc B, Eris S, Gulfirat NE, Ozden-Yilmaz G, Cakiroglu E, Coskun Deniz OS, et al. Integrative multi-omics identifies AP-1 transcription factor as a targetable mediator of acquired osimertinib resistance in non-small cell lung cancer. Cell Death Disease. 2025;16(1):414. https:\/\/doi.org\/10.1038\/s41419-025-07711-z.","journal-title":"Cell Death Disease"},{"issue":"1","key":"8886_CR48","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12967-025-06304-w","volume":"23","author":"X Liu","year":"2025","unstructured":"Liu X, Zhang X, Zeng T, Chen Y, Ye L, Wang S, et al. FOSL1 drives the malignant progression of pancreatic cancer cells by regulating cell stemness, metastasis and multidrug efflux system. J Transl Med. 2025;23(1):268. https:\/\/doi.org\/10.1186\/s12967-025-06304-w.","journal-title":"J Transl Med"},{"key":"8886_CR49","doi-asserted-by":"publisher","unstructured":"Wang W, Yun B, Hoyle RG, Ma Z, Zaman SU, Xiong G, et al. CYTOR facilitates formation of FOSL1 phase separation and super enhancers to drive metastasis of tumor budding cells in head and neck squamous cell carcinoma. Adv Sci (Weinheim, Baden-Wurttemberg, Germany). 2024;11(4):e2305002. https:\/\/doi.org\/10.1002\/advs.202305002.","DOI":"10.1002\/advs.202305002"},{"issue":"1","key":"8886_CR50","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/s41419-025-07810-x","volume":"16","author":"JE Aggrey-Fynn","year":"2025","unstructured":"Aggrey-Fynn JE, Manjunath M, Rajput A, Abdelrahman AM, Thiel J, Truty MJ, et al. Therapeutic targeting of FOSL1 and RELA-dependent transcriptional mechanisms to suppress pancreatic cancer metastasis. Cell Death Disease. 2025;16(1):504. https:\/\/doi.org\/10.1038\/s41419-025-07810-x.","journal-title":"Cell Death Disease"},{"issue":"1","key":"8886_CR51","doi-asserted-by":"publisher","first-page":"112153","DOI":"10.1016\/j.yexcr.2020.112153","volume":"394","author":"M Li","year":"2020","unstructured":"Li M, Wang J, Wang C, Xia L, Xu J, Xie X, et al. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis. Exp Cell Res. 2020;394(1):112153. https:\/\/doi.org\/10.1016\/j.yexcr.2020.112153.","journal-title":"Exp Cell Res"},{"key":"8886_CR52","doi-asserted-by":"publisher","first-page":"217731","DOI":"10.1016\/j.canlet.2025.217731","volume":"623","author":"Q Liu","year":"2025","unstructured":"Liu Q, Yu M, Lin Z, Wu L, Xia P, Zhu M, et al. COL1A1-positive endothelial cells promote gastric cancer progression via the ANGPTL4-SDC4 axis driven by endothelial-to-mesenchymal transition. Cancer Lett. 2025;623:217731. https:\/\/doi.org\/10.1016\/j.canlet.2025.217731.","journal-title":"Cancer Lett"},{"issue":"3","key":"8886_CR53","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41419-022-04689-w","volume":"13","author":"Y Meng","year":"2022","unstructured":"Meng Y, Sang Y, Liao J, Zhao Q, Qu S, Li R, et al. Single cell transcriptional diversity and intercellular crosstalk of human liver cancer. Cell Death Disease. 2022;13(3):261. https:\/\/doi.org\/10.1038\/s41419-022-04689-w.","journal-title":"Cell Death Disease"},{"issue":"16","key":"8886_CR54","doi-asserted-by":"publisher","first-page":"9341","DOI":"10.3390\/ijms23169341","volume":"23","author":"JM Han","year":"2022","unstructured":"Han JM, Jung HJ. Cyclophilin A\/CD147 interaction: a promising target for anticancer therapy. Int J Mol Sci. 2022;23(16):9341. https:\/\/doi.org\/10.3390\/ijms23169341.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"8886_CR55","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/1535-7163.MCT-15-0427","volume":"15","author":"SY Park","year":"2016","unstructured":"Park SY, Piao Y, Jeong KJ, Dong J, de Groot JF. Periostin (POSTN) regulates tumor resistance to antiangiogenic therapy in glioma models. Mol Cancer Ther. 2016;15(9):2187\u201397. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0427.","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"8886_CR56","doi-asserted-by":"publisher","first-page":"112090","DOI":"10.1016\/j.celrep.2023.112090","volume":"42","author":"T Wei","year":"2023","unstructured":"Wei T, Wang K, Liu S, Fang Y, Hong Z, Liu Y, et al. Periostin deficiency reduces PD-1(+) tumor-associated macrophage infiltration and enhances anti-PD-1 efficacy in colorectal cancer. Cell Rep. 2023;42(2):112090. https:\/\/doi.org\/10.1016\/j.celrep.2023.112090.","journal-title":"Cell Rep"},{"issue":"2","key":"8886_CR57","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41591-022-02181-8","volume":"29","author":"J Tian","year":"2023","unstructured":"Tian J, Chen JH, Chao SX, Pelka K, Giannakis M, Hess J, et al. Combined PD-1, BRAF and MEK inhibition in BRAF(V600E) colorectal cancer: a phase 2 trial. Nat Med. 2023;29(2):458\u201366.","journal-title":"Nat Med"},{"issue":"13","key":"8886_CR58","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1158\/1078-0432.CCR-23-0046","volume":"29","author":"S Leboulleux","year":"2023","unstructured":"Leboulleux S, Do Cao C, Zerdoud S, Attard M, Bournaud C, Lacroix L, et al. A phase II redifferentiation trial with dabrafenib-trametinib and 131I in metastatic radioactive iodine refractory BRAF p.V600E-mutated differentiated thyroid cancer. Clin Cancer Res: Off J Am Assoc Cancer Res. 2023;29(13):2401\u201309. https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-0046.","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"issue":"6","key":"8886_CR59","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2022.07.076","volume":"163","author":"J Datta","year":"2022","unstructured":"Datta J, Dai X, Bianchi A, De Castro Silva I, Mehra S, Garrido VT, et al. Combined MEK and STAT3 inhibition uncovers stromal plasticity by enriching for cancer-associated fibroblasts with mesenchymal stem cell-like features to overcome immunotherapy resistance in pancreatic cancer. Gastroenterology. 2022;163(6):1593\u2013612. https:\/\/doi.org\/10.1053\/j.gastro.2022.07.076.","journal-title":"Gastroenterology"},{"key":"8886_CR60","doi-asserted-by":"publisher","unstructured":"Huang WC, Yadav VK, Cheng WH, Wang CH, Hsieh MS, Huang TY, et al. The MEK\/ERK\/miR-21 signaling is critical in osimertinib resistance in EGFR-mutant non-small cell lung cancer cells. Cancers. 2021;13(23). https:\/\/doi.org\/10.3390\/cancers13236005.","DOI":"10.3390\/cancers13236005"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08886-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:51:07Z","timestamp":1789041067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08886-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8886"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08886-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committees and Institutional Review Boards of Bengbu Third People\u2019s Hospital, affiliated with Bengbu Medical University, and were conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants for participation in this study. Written informed consent was also obtained for the publication of any potentially identifiable images or data included in this article. All animal procedures were reviewed and approved by the Animal Ethics Committee of Bengbu Third People\u2019s Hospital and were conducted in accordance with institutional guidelines and applicable regulations.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have provided their consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that no conflict of interest exists.","order":3,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1167"}}